MicroRNA-181 Variants Regulate T Cell Phenotype in the Context of Autoimmune Neuroinflammation

Samira Ghorbani1,2, Farideh Talebi1, Wing Fuk Chan3

  • 1Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

Insights

MicroRNAs miR-181a and miR-181b show reduced expression in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). Their restoration suppresses inflammation and influences immune cell differentiation, offering potential MS therapeutic strategies.

Area of Science:

  • Neuroimmunology
  • Molecular Biology
  • Genetics

Background:

  • Multiple sclerosis (MS) lesions exhibit distinct microRNA (miRNA) expression profiles.
  • Altered expression of miR-181 family members in MS tissues suggests a role in pathogenesis, though not fully elucidated.
  • This study investigates the specific involvement of miR-181a and miR-181b in MS and its animal model, experimental autoimmune encephalomyelitis (EAE).

Purpose of the Study:

  • To investigate the role of miR-181a and miR-181b in the pathogenesis of multiple sclerosis (MS).
  • To examine the impact of miR-181a and miR-181b on immune cell differentiation and function in the context of autoimmune neuroinflammation.
  • To identify potential therapeutic targets for controlling inflammation in MS.

Main Methods:

  • Quantification of miR-181a and miR-181b levels in central nervous system (CNS) tissues from MS patients and EAE mice using real-time RT-PCR.
  • Transfection of miR-181a and miR-181b mimics into primary macrophages and CD4+ T cells to assess effects on differentiation and gene expression via RT-PCR and flow cytometry.
  • Luciferase reporter assays to identify direct targets of miR-181a and miR-181b, with subsequent validation in relevant cell types and disease models.

Main Results:

  • Significant downregulation of miR-181a and miR-181b was observed in MS patient brain white matter and EAE mouse spinal cords during active and chronic disease phases.
  • Overexpression of miR-181a and miR-181b mimics reduced pro-inflammatory gene expression and M1 polarization in macrophages.
  • miR-181a and miR-181b mimic transfection inhibited Th1 cell generation and promoted regulatory T cell (Treg) differentiation in CD4+ T cells.
  • Suppressor of mothers against decapentaplegic 7 (Smad7) was identified as a direct target of miR-181a and miR-181b.

Conclusions:

  • Data indicate significant anti-inflammatory actions of miR-181a and miR-181b in autoimmune neuroinflammation.
  • These miRNAs modulate T helper cell differentiation and macrophage activation, crucial processes in MS pathogenesis.
  • Restoring miR-181a and miR-181b levels presents a potential therapeutic strategy for managing inflammation in multiple sclerosis.